SCHEMBL8549313

SCHEMBL8549313

CCCCCN1CCC(c2coc3ccc(NC(=S)NCCC)cc23)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.47
SLC6A4 P31645 1/20 0.47
HTR2A P28223 6/20 0.47
DRD3 P35462 6/20 0.47
MAPK1 P28482 2/20 0.43
POLB P06746 1/20 0.43
ATM Q13315 1/20 0.43
KDM4E B2RXH2 2/20 0.42
RAD52 P43351 2/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
RECQL P46063 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
ACHE P22303 1/20 0.40
DUSP3 P51452 1/20 0.40
PTPN5 P54829 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8709640 0.89 DRD2 (0.53) DRD2SLC6A4HTR2ADRD3
SCHEMBL8707306 0.88 DRD2 (0.52) DRD2SLC6A4HTR2ADRD3
SCHEMBL8548017 0.86 DRD2 (0.50) DRD2SLC6A4HTR2ADRD3
SCHEMBL8548067 0.83 KMT2A (0.41) DRD2SLC6A4HTR2ADRD3MAPK1
SCHEMBL8549309 0.83 UBE2M (0.39) DRD2SLC6A4
SCHEMBL8552345 0.82 DRD2 (0.54) DRD2SLC6A4HTR2ADRD3
SCHEMBL8548019 0.82 DRD2 (0.49) DRD2SLC6A4HTR2ADRD3
SCHEMBL8548871 0.82 DRD2 (0.41) DRD2SLC6A4HTR2ADRD3RAB9A
SCHEMBL8703719 0.81 DRD2 (0.53) DRD2SLC6A4HTR2ADRD3
SCHEMBL8550206 0.81 DRD2 (0.47) DRD2SLC6A4MAPK1POLBATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5792763-A MIGRAINES; ANALGESICS; DISEASES LINKED TO DECREASED NEUROTRANMISSION OF SEROTONIN IN MAMMALS ELI LILLY AND COMPANY (US) 1998-08-11 US disclosed
EP-0835869-A2 New serotonin 5-HT1F agonists ELI LILLY AND COMPANY (US) 1998-04-15 EP disclosed